Implications of Scavenger Receptors in the Safe Development of Nanotherapeutics

Abstract

Nanomaterials (NMs) are being utilized in a variety of biomedical applications including drug delivery, diagnostics, and therapeutic targeting. These applications are made possible due to the unique physicochemical properties that are exhibited at the nanoscale. To ensure safe development of NMs for clinical use, it is necessary to understand their interactions with cells and specifically cell surface receptors, which will facilitate either their toxicity and/or clinical function. Recently our research and others have investigated the role of scavenger receptors in mediating NM-cell interactions and responses. Scavenger receptors are expressed by a variety of cell types that are first to encounter NMs during clinical use such as macrophages and endothelial cells. Scavenger receptors are recognized to facilitate uptake of a wide variety of ligands ranging from foreign substances to endogenous lipids/proteins. While interaction of NMs with scavenger receptors may allow therapeutic targeting in some instances, it also presents a challenge for the stealth delivery of NMs and avoidance of the scavenging capability of this class of receptors. Due to their role in facilitating immune responses, scavenger receptor-mediated inflammation is also of concern following NM delivery. The research highlighted in this brief review intends to summarize our current understanding regarding the consequences of NM-scavenger receptor interactions.

Defining Endocytic Pathways of Fucoidan-Coated PIBCA Nanoparticles from the Design of their Surface Architecture

“…Through this pathway, nanoparticles are expected to accumulate in the cytoplasm, in agreement with what was observed in the Fig. 4A ( 48 ) . Other receptors, including the C-type lectin receptors (CLRs) and the mannose receptor (MR), can bind the fucose moieties of which fucoidan is composed.…”

Nanophysical Mapping of Inflammasome Activation by Nanoparticles via Specific Cell Surface Recognition Events

“…It has been widely reported that in physiologically relevant conditions, nanomaterials are mostly taken up the cell surface machinery through energy-driven processes, indicating the involvement of receptors in nanomaterial recognition. , Cell surface receptors typically expressed in monocytes and macrophages include Toll-like receptors (TLRs), Fc receptors (FcRs), and scavenger receptors (SRs) . While TLRs seem to play a role in the priming step, recent studies point toward the involvement of SRs in nanomaterials recognition in a variety of cell lines, suggesting a possible mediating role of SRs on silica nanoparticle uptake and triggering of the NLRP3 inflammasome activation cascade. ,− …”

Mechanisms Involved in Microglial-Interceded Alzheimer’s Disease and Nanocarrier-Based Treatment Approaches

“…SR-A1 and CD36 are also PRR members and play a pivotal role in Aβ aggregation. Polystyrene-based and silver nanocarriers have been shown to interact with these receptors and inhibit microglial-mediated neuroinflammation [139]. Veglianese et al explored the role of PEG-conjugated nanocarriers in the delivery of minocycline across the BBB, demonstrating that these nanocarriers significantly inhibited microglial activation and reduced microglial activated neuroinflammation [140].…”